Single-arm Extension Study on the Safety of Cinacalcet Treatment in SHPT in Pediatric Subjects With CKD on Dialysis
Condition: Secondary Hyperparathyroidism, Chronic Kidney DiseaseIntervention: Drug: CinacalcetSponsor: AmgenNot yet recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2014 Category: Research Source Type: clinical trials
Single-arm Extension Study on the Safety of Cinacalcet Treatment in SHPT in Pediatric Subjects With CKD on Dialysis
Condition: Secondary Hyperparathyroidism, Chronic Kidney DiseaseIntervention: Drug: CinacalcetSponsor: AmgenNot yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2014 Category: Research Source Type: clinical trials
Single-arm Extension Study on the Safety of Cinacalcet Treatment in SHPT in Pediatric Subjects With CKD on Dialysis
Condition: Secondary Hyperparathyroidism, Chronic Kidney DiseaseIntervention: Drug: CinacalcetSponsor: AmgenNot yet recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2014 Category: Research Source Type: clinical trials
Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?
Condition: Primary HyperparathyroidismInterventions: Drug: Cinacalcet; Procedure: parathyroid adenomectomySponsors: Karolinska University Hospital; Karolinska InstitutetRecruiting - verified August 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2014 Category: Research Source Type: clinical trials
Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?
Condition: Primary HyperparathyroidismInterventions: Drug: Cinacalcet; Procedure: parathyroid adenomectomySponsors: Karolinska University Hospital; Karolinska InstitutetRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2014 Category: Research Source Type: clinical trials
A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis
Condition: Secondary HyperparathyroidismInterventions: Drug: ASP7991; Drug: Cinacalcet; Drug: PlaceboSponsor: Astellas Pharma IncRecruiting - verified May 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2014 Category: Research Source Type: clinical trials
